Correlation Between Bright Minds and Neximmune

Can any of the company-specific risk be diversified away by investing in both Bright Minds and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bright Minds and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bright Minds Biosciences and Neximmune, you can compare the effects of market volatilities on Bright Minds and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bright Minds with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bright Minds and Neximmune.

Diversification Opportunities for Bright Minds and Neximmune

0.0

Correlation Coefficient

Bright Minds  Neximmune

Pay attention - limited upside

The 3 months correlation between Bright and Neximmune is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bright Minds Biosciences and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Bright Minds is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bright Minds Biosciences are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Bright Minds i.e., Bright Minds and Neximmune go up and down completely randomly.

Pair Corralation between Bright Minds and Neximmune

If you would invest  3,686  in Bright Minds Biosciences on December 30, 2024 and sell it today you would lose (36.00) from holding Bright Minds Biosciences or give up 0.98% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Bright Minds Biosciences  vs.  Neximmune

Bright Minds Biosciences

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Bright Minds Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Bright Minds may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Neximmune

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neximmune has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Neximmune is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Bright Minds and Neximmune

The main advantage of trading using opposite Bright Minds and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bright Minds position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.

The idea behind Bright Minds Biosciences and Neximmune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.